Zogenix receives FDA approval of new formulation of Zohydro(R) ER
Zogenix announced the FDA has approved a new formulation of Zohydro® ER (hydrocodone bitartrate) Extended-Release Capsules, CII, with BeadTek™. BeadTek is a formulation technology designed to provide abuse-deterrent properties without changing the release properties of hydrocodone. January 30, 2015